OTCMKTS:LCDX Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 09/3/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LCDX alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.05VolumeN/AAverage Volume7,193 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Caliber Imaging & Diagnostics, Inc. is a medical technology company focused on developing advanced imaging solutions that quantify trace elemental composition in human tissue. The firm’s core technology leverages spectral analysis methods adapted from mass spectrometry to deliver non-invasive, point-of-care measurements of bone health and related physiological parameters. By translating elemental imaging into a clinical setting, Caliber Imaging aims to enhance disease screening and monitoring for conditions such as osteoporosis and other metabolic bone disorders. The company’s flagship product line features compact imaging devices designed to integrate into hospital and outpatient environments. These systems employ patented ionization and detection techniques to provide rapid, quantitative data on elements such as calcium and potassium within bone or soft tissue. Caliber Imaging’s platform offers clinicians an alternative to conventional radiographic densitometry by supplying elemental concentration maps that can improve diagnostic accuracy and support personalized treatment plans. Originally established as Astrotech Analytical, Caliber Imaging & Diagnostics emerged following a strategic shift from space and environmental instrumentation to healthcare applications. The enterprise is headquartered in The Woodlands, Texas, and maintains research collaborations with academic and clinical institutions across North America. Caliber Imaging’s management team combines expertise in analytical chemistry, biomedical engineering, and regulatory affairs to guide the company through development, validation, and commercialization phases.AI Generated. May Contain Errors. Read More Receive LCDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Caliber Imaging & Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LCDX Stock News HeadlinesCaliber Imaging & Diagnostic (LCDX) Gets a Hold from Morgan StanleyOctober 8, 2025 | theglobeandmail.comCaliber Imaging & Diagnostic (LCDX) Gets a Hold from Cantor FitzgeraldOctober 8, 2025 | theglobeandmail.comA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.September 4 at 1:00 AM | Investors Alley (Ad)Stifel Nicolaus Sticks to Its Buy Rating for Caliber Imaging & Diagnostic (LCDX)February 28, 2025 | markets.businessinsider.comLCDX Caliber Imaging & Diagnostics, Inc.February 27, 2025 | seekingalpha.comCaliber Imaging & Diagnostic (LCDX) was downgraded to a Sell Rating at Bank of America SecuritiesFebruary 26, 2025 | markets.businessinsider.comCaliber Imaging & Diagnostics IncDecember 29, 2024 | morningstar.comMCaliber Imaging & Diagnostics, Inc. (LCDX)February 9, 2024 | nz.finance.yahoo.comSee More Headlines LCDX Stock Analysis - Frequently Asked Questions How have LCDX shares performed this year? Caliber Imaging & Diagnostics' stock was trading at $0.0006 at the beginning of the year. Since then, LCDX shares have increased by 0.0% and is now trading at $0.0006. How do I buy shares of Caliber Imaging & Diagnostics? Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Caliber Imaging & Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Caliber Imaging & Diagnostics investors own include NIO (NIO), Tesla (TSLA), Costco Wholesale (COST), NVIDIA (NVDA) and Advanced Micro Devices (AMD). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:LCDX CIKN/A Webwww.caliberid.com Phone585-239-9800FaxN/AEmployees28Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:LCDX) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersFDA Momentum is Building Around NNVC!NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies ...Smallcaps Daily | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredCongress Just Opened the FloodgatesThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredAnthropic’s confidential SEC filing — and the public ticker that holds itAnthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caliber Imaging & Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caliber Imaging & Diagnostics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.